284 related articles for article (PubMed ID: 6204542)
21. Effect of cholecystokinin octapeptide and somatostatin on the motility of guinea pig and canine gallbladder.
Rakovska A; Milenov K; Bocheva A
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1989; 94(2):649-53. PubMed ID: 2576794
[TBL] [Abstract][Full Text] [Related]
22. Interaction of gastrin I, secretin, and cholecystokinin on gallbladder smooth muscle.
Ryan J; Cohen S
Am J Physiol; 1976 Mar; 230(3):553-6. PubMed ID: 1266957
[TBL] [Abstract][Full Text] [Related]
23. Benzodiazepine analogues L365,260 and L364,718 as gastrin and pancreatic CCK receptor antagonists.
Huang SC; Zhang L; Chiang HC; Wank SA; Maton PN; Gardner JD; Jensen RT
Am J Physiol; 1989 Jul; 257(1 Pt 1):G169-74. PubMed ID: 2473653
[TBL] [Abstract][Full Text] [Related]
24. Chicken gastrin: a member of the gastrin/CCK family with novel structure-activity relationships.
Dimaline R; Lee CM
Am J Physiol; 1990 Nov; 259(5 Pt 1):G882-8. PubMed ID: 2240228
[TBL] [Abstract][Full Text] [Related]
25. Bioactivity of synthetic human cholecystokinin (CCK)-33 in vitro and in vivo.
Shinozaki H; Miyasaka K; Wakasugi H; Fujii N; Funakoshi A
Gastroenterol Jpn; 1991 Feb; 26(1):51-5. PubMed ID: 1706670
[TBL] [Abstract][Full Text] [Related]
26. Discovery of a cholecystokinin analogue with partial agonist activity.
Howard JM; Knight M; Jensen RT; Gardner JD
Am J Physiol; 1984 Sep; 247(3 Pt 1):G261-4. PubMed ID: 6206732
[TBL] [Abstract][Full Text] [Related]
27. In-vitro bioassays for cholecystokinin.
Sjödin L; Nederman T; Olsson PA; Viitanen E
J Pharm Pharmacol; 1989 Jun; 41(6):402-6. PubMed ID: 2476543
[TBL] [Abstract][Full Text] [Related]
28. Relative bioactivities of cholecystokinins-8 and -33 on rat pancreatic acini.
Liddle RA; Elashoff J; Reeve JR
Peptides; 1986; 7(5):723-7. PubMed ID: 2432584
[TBL] [Abstract][Full Text] [Related]
29. Caerulein-induced acute pancreatitis in the rat. Pancreatic secretory response to cholecystokinin.
San Román JI; De Dios I; Manso MA; Calvo JJ; López MA
Arch Int Physiol Biochim; 1990 Oct; 98(5):237-43. PubMed ID: 1708991
[TBL] [Abstract][Full Text] [Related]
30. Cholecystokinin (pancreozymin). 4. Synthesis and properties of a biologically active analogue of the C-terminal heptapeptide with epsilon-hydroxynorleucine sulfate replacing tyrosine sulfate.
Bodanszky M; Martinez J; Priestley GP; Gardner JD; Mutt V
J Med Chem; 1978 Oct; 21(10):1030-5. PubMed ID: 722712
[TBL] [Abstract][Full Text] [Related]
31. Cholecystokinin octapeptide, caerulein and caerulein analogues: effects on thermoregulation in the mouse.
Zetler G
Neuropharmacology; 1982 Aug; 21(8):795-801. PubMed ID: 6289160
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological characterization of new cholecystokinin analogues.
Maletínská L; Lignon MF; Galas MC; Bernad N; Pírková J; Hlavácek J; Slaninová J; Martinez J
Eur J Pharmacol; 1992 Nov; 222(2-3):233-40. PubMed ID: 1280592
[TBL] [Abstract][Full Text] [Related]
33. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
[TBL] [Abstract][Full Text] [Related]
34. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat.
Hajri A; Aprahamian M; Damgé C
Digestion; 1989; 43(1-2):66-72. PubMed ID: 2806757
[TBL] [Abstract][Full Text] [Related]
35. Absence of effect of somatostatin on the guinea pig gallbladder.
Poitras P; Yamada T; Walsh JH
Can J Physiol Pharmacol; 1980 Feb; 58(2):179-82. PubMed ID: 6103746
[TBL] [Abstract][Full Text] [Related]
36. Evidence for two cholecystokinin receptors mediating the contraction of the guinea pig isolated ileum longitudinal muscle myenteric plexus.
Dal Forno G; Pietra C; Urciuoli M; van Amsterdam FT; Toson G; Gaviraghi G; Trist D
J Pharmacol Exp Ther; 1992 Jun; 261(3):1056-63. PubMed ID: 1602372
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and some pharmacological properties of Z-Tyr(SO3H)-Met-Gly-Trp-Met-Asp(Phe-NH2)-OH, a 32-beta-aspartyl analogue of cholecystokinin (pancreozymin) 27-33.
Martinez J; Winternitz F; Bodanszky M; Gardner JD; Walker MD; Mutt V
J Med Chem; 1982 May; 25(5):589-93. PubMed ID: 6177857
[TBL] [Abstract][Full Text] [Related]
38. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini.
Gardner JD; Knight M; Sutliff VE; Jensen RT
Am J Physiol; 1985 Jan; 248(1 Pt 1):G98-102. PubMed ID: 2578257
[TBL] [Abstract][Full Text] [Related]
39. Effect of desamino-cholecystokinin-octapeptide (CCK-7) on the intraluminal pressure and myoelectrical activity of the gall-bladder, stomach, and small intestine in conscious dogs.
Milenov E; Nieber K; Niedrich H; Oehme P; Vogt WE
Br J Pharmacol; 1983 Dec; 80(4):681-9. PubMed ID: 6100845
[TBL] [Abstract][Full Text] [Related]
40. [Addition of albumin to solutions of cholecystokinin (CCK)--effect on pancreatic secretion, plasma CCK level and release of pancreatic polypeptide (PP)].
Fried M; Gyr K; Beglinger C; Schlegel W; Grötzinger U; Stalder GA; Varga L
Z Gastroenterol; 1983 Mar; 21(3):129-33. PubMed ID: 6868720
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
